Back to Search
Start Over
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use.
- Source :
- ACS Medicinal Chemistry Letters; 4/13/2023, Vol. 14 Issue 4, p396-404, 9p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 19485875
- Volume :
- 14
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- ACS Medicinal Chemistry Letters
- Publication Type :
- Academic Journal
- Accession number :
- 163135134
- Full Text :
- https://doi.org/10.1021/acsmedchemlett.3c00006